Quanome Technologies, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $17.8M | $18.3M | $12.9M |
| Cost of Revenue | $14.9M | $14.6M | $10.3M |
| Gross Profit | $2.9M | $3.7M | $2.6M |
| Gross Margin | 16.2% | 20.3% | 19.9% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $7.4M | $4.1M | $2.3M |
| Operating Income | $-5.0M | $-526.0K | $246.9K |
| Operating Margin | -27.9% | -2.9% | 1.9% |
| Interest Expense | $139.0K | $9.2K | $11.5K |
| Pretax Income | $-4.9M | $-295.6K | $1.0M |
| Income Tax Expense | $301.9K | $-67.3K | $65.1K |
| Net Income | $-5.2M | $-225.3K | $983.6K |
| Net Margin | -29.5% | -1.2% | 7.6% |
| EPS (Basic) | $-0.69 | $-0.04 | $0.16 |
| EPS (Diluted) | $-0.69 | $-0.04 | $0.16 |
| Shares Outstanding (Basic) | 7.6M | 6.0M | 6.0M |
| Shares Outstanding (Diluted) | 7.6M | 6.0M | 6.0M |
| Dividends Per Share | — | — | — |